PeptiDream is a global Japanese biotechnology leader specializing in the development of innovative peptide therapeutics. Through its proprietary Peptide Discovery Platform System (PDPS), the company is revolutionizing drug discovery and the development of novel medicines.
Date confirmed from the Tokyo Stock Exchange (JPX) announcement schedule.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Peptidream is scheduled to report its next quarterly earnings on 11/11/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Peptidream last reported quarterly earnings on 8/12/2026 (Q2 2026). Earnings per share (EPS) came in at -8.89 JPY.
Across its last 3 earnings reports, Peptidream stock moved by ±1.7% on average the following day. The largest reaction was +3.3% on 02/16/2026; 2 of 3 reactions were positive.
Peptidream has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.